We are live on ! Find out more
Globeflex Capital

Globeflex Capital Portfolio holdings

AUM $783M Turnover 28.73%
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P icon
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CRS icon
51
Carpenter Technology
CRS
$14B
$4.9M 0.63%
7,937
+708
+10% +$333K
2024 Q3
7 quarters
NBIX icon
52
Neurocrine Biosciences
NBIX
$14.9B
$4.78M 0.61%
28,363
+190
+0.7% +$28.2K
2022 Q3
15 quarters
AMAL icon
53
Amalgamated Financial
AMAL
$1.5B
$4.75M 0.61%
103,401
-3,546
-3% -$150K
2021 Q4
18 quarters
APPS icon
54
Digital Turbine
APPS
$1.08B
$4.75M 0.61%
367,860
-58,046
-14% -$347K
2026 Q1
1 quarter
NBN icon
55
Northeast Bank
NBN
$1.07B
$4.68M 0.6%
35,339
– –
2021 Q4
18 quarters
PLOW icon
56
Douglas Dynamics
PLOW
$911M
$4.67M 0.6%
86,594
– –
2024 Q3
7 quarters
TOST icon
57
Toast
TOST
$18.3B
$4.53M 0.58%
162,676
+425
+0.3% +$11.1K
2024 Q1
9 quarters
RNG icon
58
RingCentral
RNG
$6.8B
$4.47M 0.57%
114,766
+327
+0.3% +$13.2K
2022 Q4
14 quarters
RIGL icon
59
Rigel Pharmaceuticals
RIGL
$958M
$4.41M 0.56%
112,672
-105,167
-48% -$3.24M
2024 Q3
7 quarters
VCYT icon
60
Veracyte
VCYT
$4.02B
$4.38M 0.56%
74,576
+68,812
+1,194% +$2.89M
2025 Q3
3 quarters
HSHP icon
61
Himalaya Shipping
HSHP
$766M
$4.26M 0.54%
318,651
– –
2025 Q4
2 quarters
OOMA icon
62
Ooma
OOMA
$550M
$4.24M 0.54%
220,363
– –
2024 Q2
8 quarters
RUSHB icon
63
Rush Enterprises Class B
RUSHB
$6.62B
$4.16M 0.53%
81,632
-7,381
-8% -$343K
2020 Q4
22 quarters
PNTG icon
64
Pennant Group
PNTG
$1.46B
$4.13M 0.53%
111,813
– –
2023 Q4
10 quarters
DRS icon
65
Leonardo DRS
DRS
$10B
$3.99M 0.51%
+93,547
New +$4.16M
2026 Q2
0 quarters
ACEL icon
66
Accel Entertainment
ACEL
$922M
$3.89M 0.5%
308,784
-54,208
-15% -$657K
2023 Q2
12 quarters
LEVI icon
67
Levi Strauss
LEVI
$8.63B
$3.83M 0.49%
154,443
– –
2025 Q3
3 quarters
P icon
68
Everpure Inc
P
$42.3B
$3.69M 0.47%
+46,820
New +$3.43M
2026 Q2
0 quarters
G icon
69
Genpact
G
$6.63B
$3.63M 0.46%
131,887
+427
+0.3% +$14K
2016 Q4
38 quarters
CRNC icon
70
Cerence
CRNC
$366M
$3.5M 0.45%
+308,748
New +$3.02M
2026 Q2
0 quarters
DVA icon
71
DaVita
DVA
$11.8B
$3.44M 0.44%
15,451
+2,391
+18% +$434K
2023 Q2
12 quarters
INN icon
72
Summit Hotel Properties
INN
$768M
$3.42M 0.44%
487,570
– –
2024 Q2
8 quarters
CDNA icon
73
CareDx
CDNA
$4.59B
$3.4M 0.43%
119,252
– –
2024 Q2
8 quarters
AMAT icon
74
Applied Materials
AMAT
$310B
$3.25M 0.42%
4,496
– –
2025 Q2
4 quarters
DGII icon
75
Digi International
DGII
$2.76B
$3.25M 0.42%
43,366
+7,365
+20% +$457K
2021 Q4
18 quarters

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.